Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey-Reference-Cited by-同舟云学术

Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey

Published:2019-10-31 Issue:6 Volume:33 Page:499-510
ISSN:1178-2595
Container-title:Pharmaceutical Medicine
language:en
Short-container-title:Pharm Med

Author:

Stergiopoulos Stella^ORCID,Fehrle Mortiz,Caubel Patrick,Tan Louise,Jebson Louise

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40290-019-00307-x.pdf

Reference46 articles.

1. Larizgoitia I, Bouesseau M-C, Kelley E. WHO efforts to promote reporting of adverse events and global learning. J Public Health Res. 2013;2(3):e29.

2. Pontes H, Clément M, Rollason V. Safety signal detection: the relevance of literature review. Drug Saf. 2014;37(7):471–9.

3. Pham JC, Gianci S, Battles J, et al. Establishing a global learning community for incident-reporting systems. Qual Saf Health Care. 2010;19(5):446–51.

4. Bahk CY, Goshgarian M, Donahue K, et al. Increasing patient engagement in pharmacovigilance through online community outreach and mobile reporting applications: an analysis of adverse event reporting for the essure device in the US. Pharm Med. 2015;29(6):331–40.

5. Beckmann J, Hagemann U, Bahri P, et al. Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum. Drug Saf. 2014;37(10):743–59.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing the Efficiency of the Individual Case Safety Report (ICSR) Quality and Compliance through Automation;Current Drug Safety;2024-05

2. Safety testing, clinical studies;Encyclopedia of Toxicology;2024

3. Finding Needles in the Haystack: Clinical Utility Score for Prioritisation (CUSP), an Automated Approach for Identifying Spontaneous Reports with the Highest Clinical Utility;Drug Safety;2023-08-03

4. Artificial intelligence and pharmacovigilance: What is happening, what could happen and what should happen?;Health Policy and Technology;2023-06

5. Individual Case Safety Report Replication: An Analysis of Case Reporting Transmission Networks;Drug Safety;2022-12-24